The discrepancy centers on unspecified terms, scope, or strategic rationale of the Anthropic arrangement, with Musk’s remarks diverging from what the prospectus states.

Experts warn that such divergences could temper institutional interest, widen bid-ask spreads, or lead to more cautious valuations until clarifications are issued.

SpaceX’s potential IPO is under scrutiny as Elon Musk’s public comments about the Anthropic deal appear to diverge from what’s in the IPO prospectus, raising questions about disclosure accuracy before a possible listing.

Overall, the deal could add a revenue stream and strategic positioning but complicates the financial picture SpaceX must present to investors before any IPO.

Observers note omissions in the S-1, including subscriber churn, Falcon 9 economics, AI segment granularity, and deployment metrics for compute capacity.

Due diligence is seen as critical here, given the risk that statements from leadership may misalign with regulatory filings and could affect the IPO’s credibility.

Analysts suggest using real-time data, historical trends, and scenario planning to assess risks and opportunities amid the uncertainty around SpaceX’s disclosure practices.

SpaceXAI reportedly operates at a loss with heavy capital needs; the Anthropic deal is viewed as a way to monetize existing compute infrastructure amid uncertain demand for internal AI offerings.

Previously disclosed: SpaceX leased Colossus 1 data center capacity to Anthropic at about $1.25 billion per month through May 2029 with 90 days’ termination notice; Musk hinted at a 180-day mutual cancellation, creating a filing-versus-remark discrepancy.

Industry voices are split: Cathie Wood and Ark Invest back monetizing compute infrastructure, while other experts urge timely SEC updates to align disclosures with leadership statements.

The prospectus does not specify an end date for the Anthropic deal, prompting questions about revenue forecasts and disclosure completeness for investors.

Inconsistencies between informal executive remarks and regulatory filings can impact perceptions of governance and transparency, potentially affecting investor sentiment and regulatory scrutiny.